Walter C Darbonne Selected Research

Mesothelioma

11/2021

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter C Darbonne Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 08/2006
2	Thrombocytopenia (Thrombopenia) 01/2015 - 05/2014
2	Fatigue 05/2014 - 09/2009
2	Carcinogenesis 06/2011 - 03/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Mesothelioma 11/2021
1	Disease Progression 11/2017
1	Multiple Myeloma 01/2016
1	Nausea 05/2014
1	Neutropenia 05/2014
1	Proteinuria 05/2014
1	Dysphonia (Spastic Dysphonia) 05/2014
1	Alopecia (Baldness) 05/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Medulloblastoma 04/2011
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2009
1	Hyponatremia 09/2009
1	Atrial Fibrillation 09/2009
1	Spasm (Spasms) 09/2009
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 08/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
3	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2014
3	Pharmaceutical PreparationsIBA 01/2016 - 09/2009
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2012
2	atezolizumabIBA 01/2022 - 11/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 06/2011
2	LigandsIBA 06/2011 - 03/2009
2	HhAntag691IBA 04/2011 - 09/2009
1	Immune Checkpoint InhibitorsIBA 11/2021
1	monomethyl auristatin EIBA 11/2020
1	Circulating Tumor DNAIBA 11/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	navitoclaxIBA 01/2016
1	venetoclaxIBA 01/2016
1	Ado-Trastuzumab EmtansineIBA 01/2015
1	vesencumabIBA 05/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2014
1	Monoclonal AntibodiesIBA 05/2014
1	pyrrolidineIBA 12/2013
1	dacetuzumabIBA 08/2006

Therapy/Procedure

4	Therapeutics 01/2022 - 08/2006
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 11/2021